Recent Finacing
Recent Raise
Adze Biotechnology develops systemically deliverable chimeric adenoviral oncolytic therapies engineered to evade liver clearance, restrict replication to tumor cells, and deliver immune-stimulatory transgenes and checkpoint inhibitors.